2005, a pivotal year for Axis-Shield, with strong growth and profitability

wan........excellent posts as usual.

I don't think CLIA waiver is essential to the success of Afinion although obviously it is better if they get it. You mentioned Provalis a couple of times, and it is worth remembering that even with CLIA waiver the in2it product has had a disasterous start.

I have absolutely no doubt that Afinion will achieve CLIA waiver, probably early in the new year, but it will not be until robust sales start to flow that the product will impact on revenue and profit. That may take a couple of years in my opinion. Until then, I expect growth in the region of 15% to 20%, which is still exceptional.